trending Market Intelligence /marketintelligence/en/news-insights/trending/x1jSKrss3D8qcigVO0MUXg2 content esgSubNav
In This List

AC Immune appoints chief scientific officer

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


AC Immune appoints chief scientific officer

AC Immune SA named Marie Kosco-Vilbois as chief scientific officer.

Prior to joining the company, Kosco-Vilbois was the chief scientific officer of Novimmune SA, a Switzerland-based biopharmaceutical company that develops antibody-based drugs for treating inflammatory diseases, immune-related disorders and cancer.

Kosco-Vilbois succeeds Andreas Muhs, who died. Kosco-Vilbois will report directly to CEO Andrea Pfeifer.

AC Immune, also based in Switzerland, develops therapeutics and diagnostic products to prevent and modify diseases caused by misfolding proteins.